Surgery and hormone therapy trends in octogenarians with invasive breast cancer

Am J Surg. 2016 Mar;211(3):541-5. doi: 10.1016/j.amjsurg.2015.11.005. Epub 2015 Dec 21.

Abstract

Background: There has been a trend toward minimizing surgery in elderly women with estrogen receptor-positive (ER+) breast cancer.

Methods: Using the National Cancer Data Base, we selected 95,357 women ≥80 years with invasive, ER+ breast cancer. Chi-square test and logistic regression were used to analyze trends in surgery and hormone therapy.

Results: From 2004 to 2012, 90% of women were treated with surgery first and 10% were treated with primary nonoperative management. Of those undergoing nonoperative management, 72% received endocrine therapy and 27% had no treatment. The rate of primary nonoperative treatment doubled from 7% in 2004 to 14% in 2012. Multivariate logistic regression adjusted for patient, facility, and tumor factors identified more advanced clinical stage, older age, African-American race, and treatment at Academic facilities as independent predictors of receiving primary nonsurgical management.

Conclusions: There has been an increase over time in primary nonoperative management of ER+ breast cancer in octogenarians.

Keywords: Breast cancer; Elderly; Hormone therapy; Primary endocrine therapy.

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / surgery*
  • Combined Modality Therapy
  • Female
  • Humans
  • Neoplasm Invasiveness
  • Receptors, Estrogen
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Hormonal
  • Receptors, Estrogen